IP Library Patent Application 15590444
Patent Application
App. No. 15/590,444

ACELLULAR BIOLOGIC COMPOSITION AND METHOD OF MANUFACTURE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/590,444
Abstract

A biological composition has a mixture of mechanically selected allogeneic biologic material derived from bone marrow. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.

Claims (27)

1 . A biological composition comprising:

a mixture of mechanically selected allogeneic biologic material derived from bone marrow having non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components; and

wherein the mixture is compatible with biologic function.

2 . The biological composition of claim 1 further comprises bone particles, the bone particles being added to the mixture derived from bone marrow.

3 . The biological composition of claim 2 wherein the bone particles include a mixture of cortical bone particles and cancellous bone particles.

4 . The biological composition of claim 1 wherein the mixture of mechanically selected material derived from bone marrow further includes a select number of non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts.

5 . The biological composition of claim 4 wherein the combination of non-whole cell components with a select number of the non-whole cell fractions sustains pluripotency in both graft or host cells or combinations thereof.

6 . The biological composition of claim 5 wherein the select number of the non-whole cell fractions sustains pluripotency in graft or host cells or combinations thereof includes differentiated committed cells and non-differentiated and non-committed cells.

7 . The biological composition of claim 2 wherein the biological composition is predisposed to demonstrate or support elaboration of active volume or spatial geometry consistent in morphology with that of endogenous bone.

8 . The biological composition of claim 1 wherein the biological composition extends regenerative resonance that compliments or mimics tissue complexity.

9 . The biological composition of claim 1 wherein the mixture is treated in a protectant or cryoprotectant prior to preservation or cryopreservation or freeze drying.

10 . The biological composition of claim 9 wherein the protectant or cryoprotectant creates a physical or electrical or chemical gradient or combination thereof for tissue regeneration.

11 . The biological composition of claim 10 wherein the gradient has a physical characteristic of modulus or topography such as charge density, field shape or cryo or chemo toxics tendencies.

12 . The biological composition of claim 10 wherein the gradient has a chemical characteristic of spatially changing compositions of density or species of functional molecules, wherein the molecules can offer a fixed catalytic function as a co-factor.

13 . The biological composition of claim 10 wherein the gradient has an electrical characteristic of charge based or pH based or electron affinities that confer metastability in biologic potential.

14 . The biological composition of claim 4 wherein the bone marrow mixture which is derived from a cadaver has separation-enhanced non-whole cell fractions vitality including one or more of the following: separating the fractions from cells heightens their vitality, reversing “arrest” of donors, responsive molecular coupling, matrix quest in neutralizing inflammation or satience by balancing stimulus for repair.

15 . The biological composition of claim 9 wherein the protectant or cryoprotectant is a polyampholyte.

16 . The biological composition of claim 8 wherein the regenerative resonance occurs in the presence or absence of a refractory response.

17 . The biological composition of claim 9 wherein the cryopreservation occurs at a temperature that is sub-freezing.

18 . The biological composition of claim 17 wherein the cryopreservation temperature is from 0 degrees C. to −200 degrees C.

19 . The biological composition of claim 1 wherein the mixture creates a physical or electrical or chemical gradient or combination thereof for tissue regeneration.

20 . The biological composition of claim 19 wherein the gradient has a physical characteristic such as modulus or topography.

21 . The biological composition of claim 19 wherein the gradient has a chemical characteristic such as spatially changing compositions of density or species of functional molecules.

22 . The biological composition of claim 19 wherein the gradient has an electrical characteristic such as charge based or pH based.

23 . The biological composition of claim 1 can be organelle fragments.

24 . The biological composition of claim 1 wherein active an inactive components of biological activity can be extants of the human metabolome.

25 . The biological composition of claim 9 wherein the composition is maintained at ambient temperature prior to freeze drying.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2022
From: BANKUNITED, N.A.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 061333/0853 →
SECURITY INTEREST Recorded Aug 4, 2022
From: VIVEX BIOLOGICS GROUP, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 061084/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2020
From: WESTON, WENDY W.; DELCROIX, GAETAN JEAN-ROBERT; D'IPPOLITO, GIANLUCA; GANEY, TIMOTHY; QUEVEDO, MIGUEL; OGLESBY, STUART; SCHILLER, PAUL C.
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 051967/0326 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2019
From: HERITAGE BANK OF COMMERCE
To: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
Reel/Frame 051282/0653 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 11, 2019
From: VIVEX BIOLOGICS GROUP, INC.
To: BANKUNITED, N.A.
Reel/Frame 051260/0064 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOMEDICAL, INC.
To: VIVEX BIOLOGICS, INC.
Reel/Frame 050079/0179 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOLOGICS, INC.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 050079/0225 →
SECURITY INTEREST Recorded Apr 30, 2018
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 045671/0435 →